Ert clario5/7/2023 ![]() Clario has 30 facilities in nine countries across North America, Europe and Asia Pacific. ![]() Clario's Trial Anywhere™ solutions have been powering hybrid and decentralized clinical trials (DCT) for over 15 years, enabling sponsors to collect high-quality endpoint data from any modality or location, all while improving the patient experience. Shared email addresses cannot be used for the Clario portals accounts due to regulatory requirements. Your email address must belong only to you. Note: This account is usually your individual email address. In November 2021, ERT re-branded and the company name was changed to Clario. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to empower pharmaceutical, biotech and medical device partners to transform lives. The Clario Global Account Please use your verified Clario Global Account and valid password to log in to the Clario portals. ERT (eResearchTechnology, Inc.) is a global company specializing in clinical services and customizable medical devices to biopharmaceutical and healthcare organizations. Search current jobs posted by Milwaukees top employers. Clario's new Translation Workbench technology has been developed and released to directly address those problems.įor nearly 50 years, Clario has been delivering the leading endpoint technology solutions for clinical trials. Find the best Milwaukee jobs and careers on . ERT, the global clinical endpoint technology leader, and Bioclinica, a technological and scientific leader in medical imaging, is now the. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device. ![]() A key focus of the investment is to reduce the number of manual steps often needed in the technical and complex process of delivering accurate translations. Clario delivers the leading endpoint technology solutions for clinical trials. However, they often face delays and challenges with the technical nature of the work. Reduce defects, and minimize human error through investment in automation and a new centralized data platformĬlients need reliable translation services to launch studies in multiple countries and reach a diverse patient population. Reduce the burdensome processes associated with generating accurate screenshots and translations of the related screens on eCOA applications Use new technology to reduce the time spent in communications between the Translation vendor and Clario With Clario's global reach and this investment in technology and process to reduce translation times, we can help increase patient access and speed up overall study set-up times," said Andy Cooper, EVP eCOA & Trial Enablement. "Our clients need to deploy studies in multiple countries and ensure patients have access to accurate and timely translations of their electronic clinical outcomes assessments. Clario - The best of ERT and Bioclinica (PRNewsfoto/Clario) ![]()
0 Comments
Leave a Reply. |